First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT0233581412 sitesClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Clareo Health | First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia